Former chief exeutive officer of the West Cancer Center brings over 3 decades of technology, operations, and care advancement to the OneOncology National Network.
After an extensive nationwide search, OneOncology announced today that the chief executive officer of West Cancer Center, Erich Mounce, has elected to join the national community oncology network as its first chief operating officer.
Mounce’s mission is to establish an advanced, connected network of the nation’s leading community oncology practices and position them to support the entire continuum of cancer care in any reimbursement environment. In his new role, Mounce will partner with leaders from OneOncology founding practices to optimize practice operations and integrate the latest technologies, research, and clinical trials across all OneOncology practices so that anyone living with cancer can receive world-class treatment, close to home.
“Erich’s profound domain expertise and extraordinary leadership skills will add real and lasting value to our organization,” said Tracy L. Bahl, President & CEO of OneOncology. “His extensive experience leading change in complex healthcare environments will ensure our partner practices can address all of the challenges and opportunities confronting community oncology today.”
Mounce has a proven track record of accelerating growth and working collaboratively with physicians, hospitals, and health plans to develop innovative and technologically-driven partnerships that improve healthcare delivery in the community setting.
Politics vs Science: The Future of US Public Health
February 4th 2025On this episode of Managed Care Cast, we speak with Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health, on the public health implications of the US withdrawal from the World Health Organization and the role of public health leaders in advocating for science and health.
Listen
NCCN Data Find Racial, Socioeconomic Disparities in Quality of Care for Metastatic Pancreatic Cancer
April 9th 2025New data from the National Comprehensive Cancer Network (NCCN) reveal that socially vulnerable and minority patients with metastatic pancreatic cancer are less likely to receive recommended treatments and achieve longer survival.
Read More